Pim1 Kinase Inhibitors Exert Anti-Cancer Activity Against HER2-Positive Breast Cancer Cells Through Downregulation of HER2

The proviral integration site for moloney murine leukemia virus 1 (Pim1) is a serine/threonine kinase and able to promote cell proliferation, survival and drug resistance. Overexpression of Pim1 has been observed in many cancer types and is associated with the poor prognosis of breast cancer. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bo-Wei, Huang, Chih-Hao, Liu, Liang-Chih, Cheng, Fang-Ju, Wei, Ya-Ling, Lin, Yueh-Ming, Wang, Yu-Fei, Wei, Ching-Ting, Chen, Yeh, Chen, Yun-Ju, Huang, Wei-Chien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276059/
https://www.ncbi.nlm.nih.gov/pubmed/34267653
http://dx.doi.org/10.3389/fphar.2021.614673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276059/
https://www.ncbi.nlm.nih.gov/pubmed/34267653
http://dx.doi.org/10.3389/fphar.2021.614673

Ejemplares similares